Madiha Derouazi
Chief Tech/Sci/R&D Officer at AC IMMUNE SA
Net worth: 7 271 $ as of 2024-04-29
Madiha Derouazi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AC IMMUNE SA | Chief Tech/Sci/R&D Officer | 2023-12-31 | - |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Director/Board Member | 2012-09-02 | - |
| Chief Executive Officer | 2012-09-02 | - | |
| Founder | 2012-09-02 | - |
Career history of Madiha Derouazi
Former positions of Madiha Derouazi
| Companies | Position | Start | End |
|---|
Training of Madiha Derouazi
| Technical University of Berlin | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistics
International
| Switzerland | 3 |
| Germany | 3 |
Operational
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private companies | 1 |
|---|---|
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Madiha Derouazi
- Experience
